Vincenzo Cassibba

863 total citations
12 papers, 190 citations indexed

About

Vincenzo Cassibba is a scholar working on Genetics, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine. According to data from OpenAlex, Vincenzo Cassibba has authored 12 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Public Health, Environmental and Occupational Health and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Vincenzo Cassibba's work include Chronic Lymphocytic Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and Lymphoma Diagnosis and Treatment (3 papers). Vincenzo Cassibba is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and Lymphoma Diagnosis and Treatment (3 papers). Vincenzo Cassibba collaborates with scholars based in Italy, Germany and France. Vincenzo Cassibba's co-authors include J. P. Marie, Franco Mandelli, Stefan Suciu, A. Albertí, Claudio Denzlinger, Francesco Nobile, F Beeldens, Bruno Rotoli, Roberto Stasi and Liliana Baila and has published in prestigious journals such as Blood, Leukemia and Haematologica.

In The Last Decade

Vincenzo Cassibba

8 papers receiving 187 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vincenzo Cassibba Italy	6	77	56	48	43	42	12	190
Raimundo García Spain	7	163 2.1×	93 1.7×	38 0.8×	67 1.6×	38 0.9×	8	279
Irene Dogliotti Italy	9	59 0.8×	50 0.9×	15 0.3×	33 0.8×	39 0.9×	32	165
Isabel Cano Spain	8	80 1.0×	45 0.8×	15 0.3×	27 0.6×	19 0.5×	21	154
Chongsheng Qian China	6	79 1.0×	73 1.3×	29 0.6×	36 0.8×	14 0.3×	24	212
Dai Keino Japan	7	30 0.4×	30 0.5×	27 0.6×	14 0.3×	15 0.4×	35	117
Masanori Kadowaki Japan	7	103 1.3×	61 1.1×	13 0.3×	23 0.5×	43 1.0×	20	227
Ching‐Hon Pui United States	7	80 1.0×	68 1.2×	131 2.7×	19 0.4×	47 1.1×	11	288
Tamara Belotti Italy	10	50 0.6×	31 0.6×	20 0.4×	37 0.9×	23 0.5×	16	163
M. Konopleva Russia	7	142 1.8×	27 0.5×	20 0.4×	34 0.8×	7 0.2×	33	278
Hee‐Je Kim South Korea	10	159 2.1×	75 1.3×	48 1.0×	44 1.0×	38 0.9×	38	280

Countries citing papers authored by Vincenzo Cassibba

Since Specialization

Citations

This map shows the geographic impact of Vincenzo Cassibba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincenzo Cassibba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincenzo Cassibba more than expected).

Fields of papers citing papers by Vincenzo Cassibba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincenzo Cassibba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincenzo Cassibba. The network helps show where Vincenzo Cassibba may publish in the future.

Co-authorship network of co-authors of Vincenzo Cassibba

This figure shows the co-authorship network connecting the top 25 collaborators of Vincenzo Cassibba. A scholar is included among the top collaborators of Vincenzo Cassibba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincenzo Cassibba. Vincenzo Cassibba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Hill, Theresa, Vincenzo Cassibba, Kevin Stoffel, et al.. (2023). Genetics of destemming in pepper: A step towards mechanical harvesting. Frontiers in Genetics. 14. 1114832–1114832. 8 indexed citations

Ciancaleoni, Simona, et al.. (2023). Development and Application of a Cleaved Amplified Polymorphic Sequence Marker (Phyto) Linked to the Pc5.1 Locus Conferring Resistance to Phytophthora capsici in Pepper (Capsicum annuum L.). Plants. 12(15). 2757–2757. 6 indexed citations

Piccin, Andrea, et al.. (2016). Acute Obstructive Hydrocephalus during Chemotherapy in T-Lymphoblastic Lymphoma. 2(1).

Intermesoli, Tamara, Alessandro Rambaldi, Giuseppe Rossi, et al.. (2013). High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program. Haematologica. 98(11). 1718–1725. 34 indexed citations

Bassan, Renato, Orietta Spinelli, Elena Oldani, et al.. (2012). Early Response Dynamics Including Minimal Residual Disease (MRD) and Adherence to Risk/MRD-Oriented Therapy Are Major Outcome Determinants in Adult Ph-Negative Acute Lymphoblastic Leukemia (ALL).. Blood. 120(21). 2573–2573.

Bassan, Renato, Orietta Spinelli, Elena Oldani, et al.. (2012). In Adult Acute Lymphoblastic Leukemia (ALL) Different Minimal Residual Disease (MRD) Levels Predict Clinical Outcome in All Patients and Response to Allogeneic/Autologous Transplantation in MRD-Positive Patients.. Blood. 120(21). 2493–2493.

Intermesoli, Tamara, Alessandro Rambaldi, Chiara Cattaneo, et al.. (2012). High Cure Rates in Burkitt Leukemia and Lymphoma: NILG Study of the German Short Intensive Rituximab-Chemotherapy Program. Blood. 120(21). 1494–1494.

Intermesoli, Tamara, Chiara Cattaneo, Enrico Maria Pogliani, et al.. (2012). In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Imatinib (IM) and Chemotherapy in Combination Improve Remission Rate, Stem Cell Transplantation Rate and Long-Term Outcome. Blood. 120(21). 662–662. 1 indexed citations

Amadori, Sergio, Stefan Suciu, Roberto Stasi, et al.. (2005). Gemtuzumab ozogamicin (Mylotarg®) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia Groups. Leukemia. 19(10). 1768–1773. 63 indexed citations

10.

Locasciulli, Anna, Benedetto Bruno, Emilio Paolo Alessandrino, et al.. (2003). Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation. Bone Marrow Transplantation. 31(4). 295–300. 51 indexed citations

11.

Todeschini, Giuseppe, Vittorio Meneghini, Giovanni Pizzolo, et al.. (1994). Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia.. PubMed. 8(3). 376–81. 26 indexed citations

12.

Todeschini, G, Dino Veneri, S. Carlini, et al.. (1991). Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes. Hematological Oncology. 9(3). 137–146. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact